Know Cancer

forgot password

A Randomised Controlled Trial of Lidocaine Infusion Plus Ketamine Injection Versus Placebo to Decrease Postoperative Ileus

18 Years
79 Years
Not Enrolling
Colorectal Cancer

Thank you

Trial Information

A Randomised Controlled Trial of Lidocaine Infusion Plus Ketamine Injection Versus Placebo to Decrease Postoperative Ileus

Introduction: Postoperative ileus is a normal response to the surgical handling of bowel
that causes transient impairment of bowel motility after abdominal surgery. It is
characterized by distension, absence of bowel sounds, and lack of passage of flatus and
stool. The duration of postoperative ileus is related to the degree of surgical manipulation
and the location of surgery. Colonic surgery is associated with the longest duration of
ileus. Morphine patient-controlled intravenous analgesia (PCIA) is commonly used to provide
pain control after bowel surgery. The bowel wall contains opiate receptors that decrease
bowel peristalsis in the presence of morphine. Thus, both surgery and PCIA slow return of
normal bowel function.

Lidocaine and ketamine are non-opioid analgesics that have been shown to be safe and
efficacious in low doses when combined with morphine for post-operative pain control. Since
the addition of lidocaine or ketamine to a morphine PCIA regimen results in lower total use
of morphine, and since lidocaine or ketamine does not slow peristalsis, , it is reasonable
to expect that low-dose lidocaine or ketamine plus PCIA morphine will result in faster
return of bowel function than PCIA morphine alone.

Intravenous lidocaine was first shown to relieve cancer pain in the 1950s. Since then,
intravenous lidocaine has been shown also to relieve pain after a wide variety of surgeries.
Ketamine is a non-opioid analgesic that has been shown to be safe and efficacious in very
low doses when combined with morphine for post-operative pain control . A review of ketamine
for postoperative pain control recently completed by Dr McKay has shown that ketamine is
most efficacious when given after a painful surgical insult, and that preoperative
bezodiazepines prevent ketamine-induced hallucinations (submitted for publication).
Groudine, in patients undergoing radical retropubic prostatectomy, determined that
intravenous lidocaine infusion intraoperatively decreased the duration of postoperative
ileus, decreased the pain scores postoperatively, and resulted in a 50% reduction in
morphine use, and a 20% reduction in hospitalization time. This was felt to be due to
early ambulation, earlier times to passing gas and having a bowel movement, and faster
advancement to a full diet and oral analgesics. Lidocaine plasma levels were well below
toxic range.

We propose a double-blind placebo-controlled study of patients undergoing elective or urgent
colon surgery with an anastomotic procedure. All patients will receive normal PCA morphine
in addition to study drugs or placebo. Research will be conducted at Saskatoon teaching
hospitals. This procedure was chosen as it is associated with a longer duration of ileus
compared to other abdominal surgeries and more likely to show a significant treatment

If previous data is applicable to colonic surgery then we can expect a decrease in
postoperative analgesic requirements, earlier return of bowel function, earlier progression
to full diet and earlier discharge dates.

The dose of lidocaine we propose has been shown to be safe in thousands of patients for whom
it was used to treat arrhythmias; that of ketamine in more than twenty studies of
postoperative pain control.

Inclusion Criteria:

- age 18 to 79

- booked for urgent or elective colon surgery undergoing a left, right, or transverse
hemicolectomy via laparotomy

Exclusion Criteria:

- patients requiring emergency surgery

- pregnant subjects or those who might be pregnant

- subjects allergic to lidocaine, ketamine, morphine, naproxen, or acetaminophen

- subjects with epidural analgesia

- subjects unable to understand and implement a Patient-Controlled Intravenous
Analgesia system

- subjects who do not know English well enough to understand the consent form and

- subjects with known hepatic or renal failure or cardiac dysrhythmias or
atrioventricular block

- patients with pre-existing functional bowel motility disorders including Crohn's
disease and ulcerative colitis

- daily use of laxatives, inability to have a bowel movement without laxatives, use of
suppositories or enemas on a daily basis, or use of antimotility agents

- patients with Parkinson’s disease

Type of Study:


Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention

Outcome Measure:

Mean time after surgery to completion of the following postoperative markers:

Principal Investigator

William PS McKay, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Saskatchewan


Canada: Health Canada

Study ID:

Bio-REB 03-1316



Start Date:

September 2005

Completion Date:

November 2006

Related Keywords:

  • Colorectal Cancer
  • ketamine
  • lidocaine
  • postoperative ileus
  • randomized controlled trial
  • acute postoperative pain
  • Colorectal Neoplasms